Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years

Update Il y a 4 ans
Reference: NCT01235975

Woman and Man

  • | Country :
  • Lebanon
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study evaluates the immunogenicity and safety of the meningococcal conjugate vaccine GSK 134612 given as single dose to healthy adults 56 years or older compared to the meningococcal polysaccharide vaccine MencevaxACWYTM.


Inclusion criteria

  • Infections, Meningococcal

Links